Kanda, S., Ohe, Y., Goto, Y., Horinouchi, H., Fujiwara, Y., Nokihara, H., . . . Tamura, T. (2020). Five‐year safety and efficacy data from a phase Ib study of nivolumab and chemotherapy in advanced non‐small‐cell lung cancer. Cancer Sci.

Kanda, Shintaro, Yuichiro Ohe, Yasushi Goto, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Takanori Yamamoto, and Tomohide Tamura. "Five‐year Safety and Efficacy Data From a Phase Ib Study of Nivolumab and Chemotherapy in Advanced Non‐small‐cell Lung Cancer." Cancer Sci 2020.

Kanda, Shintaro, et al. "Five‐year Safety and Efficacy Data From a Phase Ib Study of Nivolumab and Chemotherapy in Advanced Non‐small‐cell Lung Cancer." Cancer Sci 2020.